Accessibility links
Impact of the FDA's Move on Painkillers Merck and Pfizer's stocks barely budged Thursday after news that the Food and Drug Administration had asked for the removal of Bextra from the market and plans to beef up warnings on certain drug labels. Both companies have had to deal with the financial ramifications of concerns over painkillers.
NPR logo

Impact of the FDA's Move on Painkillers

Listen
  • Download
  • <iframe src="https://www.npr.org/player/embed/4581530/4581531" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
Impact of the FDA's Move on Painkillers

Business

Impact of the FDA's Move on Painkillers

Heard on All Things Considered

Impact of the FDA's Move on Painkillers

Listen
  • Download
  • <iframe src="https://www.npr.org/player/embed/4581530/4581531" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

Merck and Pfizer's stocks barely budged Thursday after news that the Food and Drug Administration had asked for the removal of Bextra from the market and plans to beef up warnings on certain drug labels. Both companies have had to deal with the financial ramifications of concerns over painkillers.